WhichRecall
Class IIReported 2026-03-25

Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 70069-025-01

Recalled by SOMERSET THERAPEUTICS LLC

Reason for Recall

Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.

Advertisement
Recall Number
D-0398-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2026-02-04
Reported
2026-03-25
Distribution
Nationwide in the USA
Code Info
Lot #: A240421, Exp 07/31/2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement